A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders

被引：11

作者：

Chen, Cynthia ^{[1
]}

Gu, Yuhan D. ^{[1
]}

Geskin, Larisa J. ^{[2
]}

机构：

[1] Columbia Univ, Vagelos Coll Phys & Surg, 161 Ft Washington Ave, New York, NY 10032 USA

[2] Columbia Univ, Dept Dermatol, 161 Ft Washington Ave, New York, NY 10032 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2019年 / 33卷 / 01期

关键词：

CD30; Lymphoproliferative; LyP; pcALCL; CTCL; LARGE-CELL LYMPHOMA; TNM CLASSIFICATION-SYSTEM; MYCOSIS-FUNGOIDES; HODGKINS-DISEASE; EUROPEAN-ORGANIZATION; BRENTUXIMAB VEDOTIN; PERIPHERAL-BLOOD; INTERFERON-ALPHA; PAPULOSIS; BEXAROTENE;

D O I：

10.1016/j.hoc.2018.08.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Primary cutaneous CD30(+) lymphoproliferative diseases (LPDs) comprise a range of diseases (LyP, pcALCL, and borderline lesions) with broad histologic and phenotypical characteristics, although they all share the common feature of a favorable prognosis notwithstanding histology suggestive of a high-grade lymphoma. Given their cytomorphologic similarities, accurate diagnosis and workup are needed to differentiate these distinct entities in order to best use novel biologic therapies and avoid aggressive overtreatment. Moreover, although CD30(+) LPDs have a favorable prognosis, secondary malignancies should be considered as part of the initial evaluation, and patients should have ongoing surveillance.

引用

页码：121 / +

页数：15

共 73 条

[1] PUSTULAR LYMPHOMATOID PAPULOSIS IN CHILDHOOD [J].

BARNADAS, MA ;

LOPEZ, D ;

PUJOL, RM ;

GARCIAPATOS, V ;

CURELL, R ;

DEMORAGAS, JM .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (04) :627-628

[2] Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment [J].

Bekkenk, MW ;

Geelen, FAMJ ;

Vader, PCV ;

Heule, F ;

Geerts, ML ;

van Vloten, WA ;

Meijer, CJLM ;

Willemze, R .

BLOOD, 2000, 95 (12) :3653-3661

[3]

BELJAARDS RC, 1993, CANCER, V71, P2097, DOI 10.1002/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO

[4]

2-7

[5] Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients [J].

Benner, M. F. ;

Willemze, R. .

BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) :1148-1151

[6]

Benner MF, 2009, ARCH DERMATOL, V145, P1399, DOI 10.1001/archdermatol.2009.280

[7] Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry [J].

Booken, Nina ;

Goerdt, Sergij ;

Klemke, Claus-Detlev .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (05) :331-340

[8] Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group [J].

Bruijn, M. S. ;

Horvath, B. ;

Vader, P. C. van Voorst ;

Willemze, R. ;

Vermeer, M. H. .

BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (05) :1319-1322

[9] Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature [J].

Burg, G ;

Kempf, W ;

Kazakov, DV ;

Dummer, R ;

Frosch, PJ ;

Lange-Ionescu, S ;

Nishikawa, T ;

Kadin, ME .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) :580-586

[10] Granulomatous eccrinotropic lymphomatoid papulosis [J].

Crowson, AN ;

Baschinsky, DY ;

Kovatich, A ;

Magro, C .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (05) :731-739

← 1 2 3 4 5 6 7 8 →